A. Wö-hrer, . Waldhö-r-t, and H. Heinzl, The Austrian brain tumour registry: a cooperative way to establish a population-based brain tumour registry, J Neurooncol, vol.95, issue.3, pp.401-411, 2009.

Q. T. Ostrom, H. Gittleman, and P. Liao, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in, Neuro Oncol, vol.16, pp.1-63, 2007.

D. N. Louis, H. Ohgaki, and O. D. Wiestler, WHO Classification of Tumors of th Central Nervous System, 2007.

M. C. Chamberlain, Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma, J Neurooncol, vol.107, issue.2, pp.315-321, 2012.

M. C. Chamberlain, D. D. Tsao-wei, and S. Groshen, Temozolomide for treatment-resistant recurrent meningioma, Neurology, vol.13, issue.7, pp.1210-1212, 2004.

M. C. Chamberlain, D. D. Tsao-wei, and S. Groshen, Salvage chemotherapy with CPT-11 for recurrent meningioma, J Neurooncol, vol.78, issue.3, pp.271-276, 2006.

M. C. Chamberlain and M. J. Glantz, Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas, Cancer, vol.15, issue.8, pp.2146-2151, 2008.

S. M. Grunberg, M. H. Weiss, and C. A. Russell, Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma, Cancer Invest, vol.24, issue.8, pp.727-733, 2006.

D. R. Johnson, D. W. Kimmel, and P. A. Burch, Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma, Neuro Oncol, vol.13, issue.5, pp.530-535, 2011.

S. M. Grunberg and M. H. Weiss, Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma, J Neurooncol, vol.8, issue.1, pp.61-65, 1990.

L. Nayak, F. M. Iwamoto, and J. D. Rudnick, Atypical and anaplastic meningiomas treated with bevacizumab, J Neurooncol, vol.109, issue.1, pp.187-193, 2012.

P. Y. Wen, W. K. Yung, and K. R. Lamborn, Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08), Neuro Oncol, vol.11, issue.6, pp.853-860, 2009.

A. D. Norden, J. J. Raizer, and L. E. Abrey, Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma, J Neurooncol, vol.96, issue.2, pp.211-217, 2010.

T. Kaley, I. Barani, and M. C. Chamberlain, Historical benchmarks for medical therapy trials in surgery-and radiation-refractory meningioma: A RANO review, Neuro Oncol, vol.16, issue.6, pp.829-840, 2014.

C. Rorden, H. O. Karnath, and L. Bonilha, Improving lesion-symptom mapping, J Cogn Neurosci, vol.19, issue.7, pp.1081-1088, 2007.

M. C. Chamberlain, M. J. Glantz, and C. E. Fadul, Recurrent meningioma: salvage therapy with long-acting somatostatin analogue, Neurology, vol.69, issue.10, pp.969-973, 2007.

J. J. Raizer, S. A. Grimm, and A. Rademaker, A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas, J Neurooncol, vol.117, issue.1, pp.93-101, 2014.

T. J. Kaley, P. Wen, and D. Schiff, Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma, Neuro Oncol, vol.17, issue.1, pp.116-121, 2015.

M. Puchner, V. H. Hans, and A. Harati, Bevacizumab-induced regression of anaplastic meningioma, Ann Oncol, vol.21, issue.12, pp.2445-2446, 2010.

P. Baumgarten, B. Brokinkel, and J. Zinke, Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas, Histol Histopathol, vol.28, issue.9, pp.1157-1166, 2013.

M. Preusser, M. Hassler, and P. Birner, Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches, Clin Neuropathol, vol.31, issue.5, pp.352-360, 2012.

V. F. Mautner, R. Nguyen, and R. Knecht, Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation, Ann Oncol, vol.21, issue.11, p.2294, 2010.

D. Nassehi, L. P. Sørensen, and H. Dyrbye, Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway, APMIS, vol.121, issue.11, pp.1025-1036, 2013.

E. Iwado, T. Ichikawa, and H. Kosaka, Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas, Neuropathology, vol.32, issue.6, pp.638-646, 2012.

S. Schmid, F. Aboul-enein, and W. Pfisterer, Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients, Neurosurgery, vol.67, issue.6, pp.1703-1708, 2010.

. Furtner, Systemic therapy of malignant meningioma